Covidien Unit To Buy Specialty Drug Co. For $100M
Covidien PLC unit Mallinckrodt LLC on Monday announced plans to take on privately held specialty pharmaceutical company CNS Therapeutics Inc. for $100 million....To view the full article, register now.
Already a subscriber? Click here to view full article